These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 1519492)

  • 21. Absence of p53 germ-line mutations in bilateral breast cancer patients.
    Lidereau R; Soussi T
    Hum Genet; 1992 May; 89(2):250-2. PubMed ID: 1587536
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Germline TP53 R337H mutation is not sufficient to establish Li-Fraumeni or Li-Fraumeni-like syndrome.
    Ribeiro RC; Rodriguez-Galindo C; Figueiredo BC; Mastellaro MJ; West AN; Kriwacki R; Zambetti GP
    Cancer Lett; 2007 Mar; 247(2):353-5; author reply 356-8. PubMed ID: 16750598
    [No Abstract]   [Full Text] [Related]  

  • 23. Correction: a Li-Fraumeni syndrome p53 mutation.
    Malkin D; Friend SH
    Science; 1993 Feb; 259(5097):878. PubMed ID: 8438145
    [No Abstract]   [Full Text] [Related]  

  • 24. Beyond Li Fraumeni Syndrome: clinical characteristics of families with p53 germline mutations.
    Gonzalez KD; Noltner KA; Buzin CH; Gu D; Wen-Fong CY; Nguyen VQ; Han JH; Lowstuter K; Longmate J; Sommer SS; Weitzel JN
    J Clin Oncol; 2009 Mar; 27(8):1250-6. PubMed ID: 19204208
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [p53 transgenic and knockout mice].
    Oda H
    Nihon Rinsho; 2000 Jun; 58(6):1250-4. PubMed ID: 10879049
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A germline 2.35 kb deletion of p53 genomic DNA creating a specific loss of the oligomerization domain inherited in a Li-Fraumeni syndrome family.
    Plummer SJ; Santibáñez-Koref M; Kurosaki T; Liao S; Noble B; Fain PR; Anton-Culver H; Casey G
    Oncogene; 1994 Nov; 9(11):3273-80. PubMed ID: 7936651
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Elevated frequency and functional activity of a specific germ-line p53 intron mutation in familial breast cancer.
    Lehman TA; Haffty BG; Carbone CJ; Bishop LR; Gumbs AA; Krishnan S; Shields PG; Modali R; Turner BC
    Cancer Res; 2000 Feb; 60(4):1062-9. PubMed ID: 10706125
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Description of a new TP53 gene germline mutation in a family with the Li-Fraumeni syndrome. Genetic counselling to healthy mutation carriers].
    Balmaña J; Nomdedéu J; Díez O; Sabaté JM; Balil A; Pericay C; López López JJ; Brunet J; Baiget M; Alonso C
    Med Clin (Barc); 2002 Oct; 119(13):497-9. PubMed ID: 12406399
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Germ-line splicing mutation of the p53 gene in a cancer-prone family.
    Warneford SG; Witton LJ; Townsend ML; Rowe PB; Reddel RR; Dalla-Pozza L; Symonds G
    Cell Growth Differ; 1992 Nov; 3(11):839-46. PubMed ID: 1467311
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Hereditary breast cancers].
    Perey L; Schorderet DF
    Praxis (Bern 1994); 1996 Aug; 85(35):1035-9. PubMed ID: 8848674
    [TBL] [Abstract][Full Text] [Related]  

  • 31. EFGR-mutant lung adenocarcinoma and Li-Fraumeni syndrome: report of two cases and review of the literature.
    Ricordel C; Labalette-Tiercin M; Lespagnol A; Kerjouan M; Dugast C; Mosser J; Desrues B; Léna H
    Lung Cancer; 2015 Jan; 87(1):80-4. PubMed ID: 25433984
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A germ line mutation in exon 5 of the p53 gene in an extended cancer family.
    Law JC; Strong LC; Chidambaram A; Ferrell RE
    Cancer Res; 1991 Dec; 51(23 Pt 1):6385-7. PubMed ID: 1933902
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Functional studies of a novel germline p53 splicing mutation identified in a patient with Li-Fraumeni-like syndrome.
    Piao J; Sakurai N; Iwamoto S; Nishioka J; Nakatani K; Komada Y; Mizutani S; Takagi M
    Mol Carcinog; 2013 Oct; 52(10):770-6. PubMed ID: 22495821
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genetic heterogeneity in breast cancer susceptibility.
    Andersen TI
    Acta Oncol; 1996; 35(4):407-10. PubMed ID: 8695152
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Familial breast cancer, ovarian cancer].
    Inoue M
    Nihon Rinsho; 2006 Jun; Suppl 2():366-70. PubMed ID: 16817423
    [No Abstract]   [Full Text] [Related]  

  • 36. [Li-Fraumeni syndrome].
    Frebourg T
    Bull Cancer; 1997 Jul; 84(7):735-40. PubMed ID: 9339200
    [TBL] [Abstract][Full Text] [Related]  

  • 37. p53 and the Li-Fraumeni syndrome.
    Malkin D
    Biochim Biophys Acta; 1994 Dec; 1198(2-3):197-213. PubMed ID: 7819275
    [No Abstract]   [Full Text] [Related]  

  • 38. p53 and the Li-Fraumeni syndrome.
    Malkin D
    Cancer Genet Cytogenet; 1993 Apr; 66(2):83-92. PubMed ID: 8500106
    [TBL] [Abstract][Full Text] [Related]  

  • 39. RNA polymerase III transcription can be derepressed by oncogenes or mutations that compromise p53 function in tumours and Li-Fraumeni syndrome.
    Stein T; Crighton D; Boyle JM; Varley JM; White RJ
    Oncogene; 2002 May; 21(19):2961-70. PubMed ID: 12082526
    [TBL] [Abstract][Full Text] [Related]  

  • 40. EGFR-mutated lung cancer in Li-Fraumeni syndrome.
    Michalarea V; Calcasola M; Cane P; Tobal K; Izatt L; Spicer J
    Lung Cancer; 2014 Sep; 85(3):485-7. PubMed ID: 25047674
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.